Peptides News and Research

RSS

New nanovaccine for deadly skin cancer

Tel Aviv scientists have published their version of a vaccine against the deadly skin cancer malignant melanoma, which arises from the pigment producing cells of the skin. This is the most feared form of skin cancer, with a high tendency to metastasize to distant parts of the body, including the brain.

6 Aug 2019

Tel Aviv researchers develop a nano-vaccine for the most aggressive skin cancer

Researchers at Tel Aviv University have developed a novel nano-vaccine for melanoma, the most aggressive type of skin cancer.

5 Aug 2019

Lactic acid bacteria and gut bacteria contribute to health benefits of rye, study shows

Eating rye comes with a variety of health benefits. A new study from the University of Eastern Finland now shows that both lactic acid bacteria and gut bacteria contribute to the health benefits of rye.

5 Aug 2019

Alzheimers may be linked to genes that code formation of contacts between neurons

A team of neurobiologists from Peter the Great St. Petersburg Polytechnic University published an article on their study of the causes of Alzheimer's disease and suggested therapy methods.

2 Aug 2019

Understanding how positively charged peptides formed on pre-biotic earth

Earth didn't always harbor life. But around 4 billion years ago, something in the environment changed, and systems with biological properties began to emerge.

2 Aug 2019

Liver function may be important in Alzheimer’s disease risk

A new study shows a strong link between altered liver function and the development of Alzheimer’s disease (AD). This correlates with recent data on the role played by diseases affecting the systemic metabolism, such as diabetes and high blood cholesterol, in disruptions of brain function as in AD.

31 Jul 2019

SGLT-2 inhibitors do not increase the risk of UTIs in diabetics, concludes study

A new study has shown that SGLT-2 inhibitors used in the treatment of type 2 diabetes do not increase the risk of UTIs over other anti-diabetic medications.

31 Jul 2019

Understanding creation of antibiotic scaffolds could drive new class of antibiotics

Understanding how antibiotic scaffolds are constructed in nature can help scientists prospect for new classes of antibiotics through DNA sequencing and genome mining.

31 Jul 2019

Antimicrobial peptides that help protect against infection defend against cancer

An antimicrobial agent called Defensin kills tumor cells and shrinks tumor size in fruit flies, with help from a pathway that flags the cells for destruction.

31 Jul 2019

Genetics may influence the composition of the microbiome more than environmental factors

Researchers have found that the microbiome is influenced by genetics much more than it is by the maternal birth environment.

29 Jul 2019

Chemists discover a whole new class of microbial recipes

Microbes are master chefs of the biomolecular world; collectively, they harbor the ability to produce a vast array of unknown substances, some of which may have therapeutic or other useful properties.

22 Jul 2019

Eisai presents new research evaluating correlation of Abeta in plasma and CSF with automated protein assay system

Eisai Co.,Ltd. announced its latest research on evaluation about correlation of amyloid beta (Abeta) in plasma and in cerebrospinal fluid (CSF) by high precision measurement with the newly developed automated protein assay system, jointly developed with Sysmex Corporation, using full automated immunoassay system HISCLTM series for creating the simplified diagnosis of Alzheimer's disease with blood was presented at the Alzheimer's Association International Conference held in Los Angeles, California, United States, from July 14 to 18, 2019.

From Eisai 19 Jul 2019

Getting rid of chronic infections by waking up sleeping bacteria

Researchers in the group of Jan Michiels (VIB-KU Leuven Center for Microbiology) identified a mechanism of how sleepy bacteria wake up.

18 Jul 2019

Researchers explain why fascioliasis patients have increased risk for neurological diseases

Fascioliasis is a parasitic disease caused by two species that are present in the liver: Hepatic Fasciola, which is present worldwide, and Fasciola gigantica, which is in Asia and Africa.

18 Jul 2019

Research opens possibility of developing single-dose gene therapy for inherited arrhythmias

Researchers at Boston Children's Hospital report creating the first human tissue model of an inherited heart arrhythmia, replicating two patients' abnormal heart rhythms in a dish, and then suppressing the arrhythmia with gene therapy in a mouse model.

17 Jul 2019

Peptides News and Research

New nanovaccine for deadly skin cancer

Tel Aviv researchers develop a nano-vaccine for the most aggressive skin cancer

Lactic acid bacteria and gut bacteria contribute to health benefits of rye, study shows

Alzheimers may be linked to genes that code formation of contacts between neurons

Understanding how positively charged peptides formed on pre-biotic earth

Liver function may be important in Alzheimer’s disease risk

SGLT-2 inhibitors do not increase the risk of UTIs in diabetics, concludes study

Understanding creation of antibiotic scaffolds could drive new class of antibiotics

Antimicrobial peptides that help protect against infection defend against cancer

Genetics may influence the composition of the microbiome more than environmental factors

Chemists discover a whole new class of microbial recipes

Eisai presents new research evaluating correlation of Abeta in plasma and CSF with automated protein assay system

Getting rid of chronic infections by waking up sleeping bacteria

Researchers explain why fascioliasis patients have increased risk for neurological diseases

Research opens possibility of developing single-dose gene therapy for inherited arrhythmias

Two New Resistance-Proof Antibiotics Have Been Created

Structure of bacteria responsible for traveler's diarrhea deciphered

Israeli scientists invent new tooth fillings to fight recurrent decay

Eggshells can enhance growth of new, strong bones

New alliance will focus on the structural visualization of novel druggable sites

Editorial Focus eBook - Peptides and Oligonucleotides (2nd edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News